GSK to strengthen presence in Asia with new strategic alliance with Dong-A

Published: 2010-07-13 06:58:00

Updated: 2010-07-13 06:58:00

With a strategic alliance with Dong-A Pharmaceuticals Co. (Dong-A) in May, GlaxoSmithKline (GSK) has a plan to promote the latter’s proprietary and generic pharmaceutical products and leading consumer healthcare brands.

“With Dong-A’s market-leading position and expertise in Korea, this allian...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK